Ottobock SE & Co. KGaA (OBOCY)
15.20
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.863B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -- |
| Valuation | |
| PE Ratio | 32.45 |
| PE Ratio (Forward) | |
| PS Ratio | 2.406 |
| Price to Book Value | 10.75 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.2256 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 3.079 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Ottobock SE & Co. KGaA engages in the research, development, manufacture, and distribution of medical technology products. It offers Prosthetics, Orthotic, and Exoskeletons solutions. Its products include C-Leg 4, C-Brace, Dynion, MyCRO Band, and Ottobock Microprocessor Knees. It provides Ottobock professional website, iFab, and GreenLine services. It operates through the following geographical segments: Europe, Middle East and Africa (EMEA), and Americas Asia Pacific (APAC). The Europe, EMEA, and APAC segments refer to the manufacturing and distributing of prosthetic, orthotic, and neurostimulation products. The company was founded by Otto Bock in 1919 and is headquartered in Duderstadt, Germany. |
| URL | http://www.ottobock.com |
| Investor Relations URL | N/A |
| HQ State/Province | Niedersachsen (Lwr Saxony) |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | N/A |
| Next Earnings Release | Nov. 12, 2026 |
| Last Earnings Release | Aug. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 28, 2026 |
Profile
| Ottobock SE & Co. KGaA engages in the research, development, manufacture, and distribution of medical technology products. It offers Prosthetics, Orthotic, and Exoskeletons solutions. Its products include C-Leg 4, C-Brace, Dynion, MyCRO Band, and Ottobock Microprocessor Knees. It provides Ottobock professional website, iFab, and GreenLine services. It operates through the following geographical segments: Europe, Middle East and Africa (EMEA), and Americas Asia Pacific (APAC). The Europe, EMEA, and APAC segments refer to the manufacturing and distributing of prosthetic, orthotic, and neurostimulation products. The company was founded by Otto Bock in 1919 and is headquartered in Duderstadt, Germany. |
| URL | http://www.ottobock.com |
| Investor Relations URL | N/A |
| HQ State/Province | Niedersachsen (Lwr Saxony) |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | N/A |
| Next Earnings Release | Nov. 12, 2026 |
| Last Earnings Release | Aug. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 28, 2026 |